• Our Offering
    • small molecules

      • Preclinical Services
      • IND/Clinical Supply
      • Drug Substance
      • API
      • Advanced Intermediate
      • Highly Potent API
      • ADC Payload
      • Solid Form Services
      • Drug Product
      • Particle Engineering
      • Bioavailability Enhancement
      • Oral Solid
      • Inhalation
      • Parenteral
    • biologics

      • Preclinical Offering
      • Expression Technologies
      • Discovery Services
      • Drug Substance
      • Mammalian
      • Microbial
      • ADCs / Bioconjugates
      • Ibex® Solutions
      • Drug Product
      • Parenteral
    • cell & gene

      • Allogeneic Cell Therapy
      • iPSC Manufacturing
      • Exosomes
      • Cell Based Immunotherapies
      • Autologous Cell Therapy
      • Cell Based Immunotherapies
      • Viral Vectors
      • Services
      • Process Development
      • cGMP Manufacturing
      • Regulatory Support
      • Tissue Acquisition
      • Products
      • Cocoon® Platform
    • bioscience

      • Primary & Stem Cells
      • Bioprocessing Media
      • CellBio Services
      • Culture Media & Reagents
      • ADME & Toxicology
      • Transfection
      • Cell Assays & Analysis
      • Electrophoresis
      • Informatics – Paperless Solutions
      • QC & Endotoxin Detection
      • Automated Sterile Sampling
    • capsules

      • Immediate Release
      • Modified Release
      • Vegetarian
      • Inhalation
      • Over the Counter (OTC)
      • IND / Clinical Supply
      • Equipment
  • Resources
      • technologies & products

        We develop proprietary technology and licensing partnerships to ensure you have access to best-in-class solutions that add value to your own science.

      • regulatory support

        In close collaboration with you, Lonza Regulatory Affairs provide a CMC dossier suitable to the stage of clinical development of your product manufactured by Lonza.

      • technical support

        The collective expertise of our multi-disciplinary team in protein expression and production processes can help you get the most from our industry-leading technologies.

      • knowledge center

        Gather additional industry and technical information from our repository of resources and educational content.

  • About Us
      • about us

        Delivering the medicines of tomorrow today

      • careers

        Find opportunities

      • news

        View press releases

      • locations

        View our locations

      • events

        the next conversation...

      • meet our experts

  • Contact Us
Our Offering
small molecules
  • Preclinical Services
  • IND/Clinical Supply
  • Drug Substance
  • API
  • Advanced Intermediate
  • Highly Potent API
  • ADC Payload
  • Solid Form Services
  • Drug Product
  • Particle Engineering
  • Bioavailability Enhancement
  • Oral Solid
  • Inhalation
  • Parenteral
biologics
  • Preclinical Offering
  • Expression Technologies
  • Discovery Services
  • Drug Substance
  • Mammalian
  • Microbial
  • ADCs / Bioconjugates
  • Ibex® Solutions
  • Drug Product
  • Parenteral
cell & gene
  • Allogeneic Cell Therapy
  • iPSC Manufacturing
  • Exosomes
  • Cell Based Immunotherapies
  • Autologous Cell Therapy
  • Cell Based Immunotherapies
  • Viral Vectors
  • Services
  • Process Development
  • cGMP Manufacturing
  • Regulatory Support
  • Tissue Acquisition
  • Products
  • Cocoon® Platform
bioscience
  • Primary & Stem Cells
  • Bioprocessing Media
  • CellBio Services
  • Culture Media & Reagents
  • ADME & Toxicology
  • Transfection
  • Cell Assays & Analysis
  • Electrophoresis
  • Informatics – Paperless Solutions
  • QC & Endotoxin Detection
  • Automated Sterile Sampling
capsules
  • Immediate Release
  • Modified Release
  • Vegetarian
  • Inhalation
  • Over the Counter (OTC)
  • IND / Clinical Supply
  • Equipment
Resources
technologies & products
regulatory support
technical support
knowledge center
About Us
about us
careers
news
locations
events
meet our experts
Contact Us

Our latest news and announcements

    • Knowledge Center
    • Offerings
    • About Us
    • Technologies & Products
    • Contact us
  • About Us
    • Locations
    • Job search
    • Events
  • News
Filter by News Category
General (149) Partnerships (40) New Products (9) Acquisitions (6) New Technologies (5) Financials (3)
Filter by Market
Pharma and Biotech (164) Corporate (22) Bioscience (8)
Filter by Year
2021 (5) 2020 (42) 2019 (29) 2018 (23) 2017 (21) 2016 (26) 2015 (12) 2014 (6)
Filter by Language
English (164)
EnglishX
Showing 161‐164 of 164
results per page
30 Oct 2014
Bristol-Myers Squibb and Lonza Expand Manufacturing Agreement
Bristol-Myers Squibb and Lonza Expand Manufacturing Agreement
04 Sep 2014
Lonza Introduces Services for Rational Vaccine Design and Development to Help Reduce the Cost of Failure and Increase the Chance of Clinical Success
Lonza Introduces Services for Rational Vaccine Design and Development to Help Reduce the Cost of Failure and Increase the Chance of Clinical Success
17 Apr 2014
Lonza’s Facility in Singapore Received Good Manufacturing Practice (GMP) Certification from the HSA
Lonza’s Facility in Singapore Received Good Manufacturing Practice (GMP) Certification from the HSA
13 Jan 2014
Lonza Extends Partnership with Pharmacyclics to Support Manufacturing of Recently Approved Oncology Therapeutic, IMBRUVICA™
Lonza Extends Partnership with Pharmacyclics to Support Manufacturing of Recently Approved Oncology Therapeutic, IMBRUVICA™
< 1 ... 6 7 8 9
About Us
  • Careers
  • Events
  • Locations
  • News
Resources
  • Knowledge Center
  • Technologies and Products
  • Technical Support
  • Regulatory Support
Terms
  • Legal Disclaimer
  • Privacy Policy
  • Sitemap
www.lonza.com
© 2021 Lonza. All Rights Reserved.
By visiting our website or using services provided by Lonza, you are accepting the practices described in the Privacy and Cookie policies.